Where does a migraine attack originate? In the brainstem

Journal of Neural Transmission

Volumn 119, Issue 5, 2012, Pages 557-568

  Tajti, J ^a   Szok, D ^a   Pardutz A ^a   Tuka, B ^a   Csa Ti A ^a   Kuris, A ^a   Toldi, J ^b   Vecsei L ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Brainstem; Electrophysiology; Functional anatomy; Kynurenines; Migraine; Neuroimaging

Indexed keywords

KYNURENINE;

BRAIN ELECTROPHYSIOLOGY; BRAIN NUCLEUS; BRAIN STEM; DEPRESSION; EYELID REFLEX; FUNCTIONAL ANATOMY; FUNCTIONAL NEUROIMAGING; HABITUATION; HUMAN; MIGRAINE; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIMARY HEADACHE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN STEM; HUMANS; MIGRAINE DISORDERS; NEURAL PATHWAYS;

EID: 84863499019     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0788-9     Document Type: Review

References (183)

1. Afridi SK, Goadsby PJ (2003) New onset migraine with a brainstem cavernous angioma. J Neurol Neurosurg Psychiatry 74:680-682
2. Afridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RSJ, Goadsby PJ (2005) A positron emission tomographic study in spontaneous migraine. Arch Neurol 62:1270-1275
3. Akerman S, Goadsby PJ (2009) VPAC1 and PAC1 receptor antagonists inhibit activation of the parasympathetic outflow to the cranial vasculature to prevent autonomic responses and neuronal firing in the trigeminocervical complex. Cephalalgia 29(Suppl. 1): 130
4. Akerman S, Holland PR, Lasalandra MP, Goadsby PJ (2009) Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents. Headache 49:1131-1143
5. Amaral DG, Sinnamon HM (1977) The locus coeruleus: neurobiology of a central noradrenergic nucleus. Prog Neurobiol 9:147-196
6. Ambrosini A, De Pasqua V, Afra J, Sandor PS, Schoenen J (2001) Reduced gating of middle-latency auditory evoked potentials (P50) in migraine patients: another indication of abnormal sensory processing? Neurosci Lett 306:132-134
7. Aurora SK, Barrodale PM, Tipton RL, Khodavirdi A (2007) Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache 47:996-1003
8. Avramidis TG, Podikoglu DG, Anastasopoulos IE, Koutroumanidis MA, Papadimitriou AL (1998) Blink reflex in migraine and tension-type headache. Headache 38:691-696
9. Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ (2001) Brainstem activation specific to migraine headache. Lancet 357:1016-1017
10. Bánk J, Bense E, Király C (1992) The blink reflex in migraine. Cephalalgia 12:289-292
11. Barbanti P, Fabbrini G, Pesare M, Vanacore N, Cerbo R (2002) Unilateral cranial autonomic symptoms in migraine. Cephalalgia 22:256-259
12. Barbanti P, Fabbrini G, Vanacore N, Pesare M, Buzzi MG (2003) Sumatriptan in migraine with unilateral cranial autonomic symptoms: an open study. Headache 43:400-403
13. Bartsch T, Goadsby PJ (2002) Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 125:1496-1509
14. Bartsch T, Goadsby PJ (2003) Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain 126:1801-1813
15. Bartsch T, Goadsby PJ (2005) Anatomy and physiology of pain referral patterns in primary and cervicogenic headache disorders. Headache Currents 2:42-48
16. Bartsch T, Knight YE, Goadsby PJ (2004) Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol 56:371-381
17. Basbaum AJ, Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Ann Rev Neurosci 7:309-338
18. Basbaum AJ, Clanton CH, Fields HL (1978) Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain-modulating systems. J Comp Neurol 178:209-224
19. Beadle GW, Mitchell HK, Nyc JF (1947) Kynurenine as an intermediate in the formation of nicotinic acid from tryptophane by neurospora. Proc Natl Acad Sci USA 33:155-158
20. Behan WM, McDonald M, Darlington LG, Stone TW (1999) Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol 128:1754-1760
21. Bernays RL, Heeb L, Cuenod M, Streit P (1988) Afferents to the rat red nucleus studied by means of D[3H]aspartate, [3H]choline and non-selective tracers. Neuroscience 26:601-619
22. Bertolino M, Vicini S, Costa E (1989) Kynurenic acid inhibits the activation of kainic and N-methyl-D-aspartic acid-sensitive ionotropic receptors by a different mechanism. Neuropharmacol 28:453-457
23. Birch PJ, Grossman CJ, Hayes AG (1988) Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Eur J Pharmacol 151:313-315
24. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8:136-142
25. Bouchelet I, Cohen Z, Case B, Seguela P, Hamel E (1996) Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol 50:219-223
26. Bruinvels AT, Landwehrmeyer B, Gustafson EL (1994) Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacol 33:367-386
27. Brun P, Suaud-Chagny MF, Lachuer J, Gonon F, Buda M (1991) Catecholamine metabolism in locus coeruleus neurons: a study of its activation by sciatic nerve stimulation in the rat. Eur J Neurosci 3:397-406
28. Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964-982
29. Burstein R, Cutrer MF, Yarnitsky D (2000a) The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703-1709
30. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000b) An association between migraine and cutaneous allodynia. Ann Neurol 47:614-624
31. Cao Y, Welch KM, Aurora S, Vikingstad EM (1999) Functional MRIBOLD of visually triggered headache in patients with migraine. Arch Neurol 56:548-554
32. Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM (2002) Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology 59:72-78
33. Chan KY, Baun M, de Vries R, van den Bogaerdt AJ, Dirven CM, Danser AH, Jansen-Olesen I, Olesen J, Villalón CM, Maassen-VanDenBrink A, Gupta S (2011) Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 31:181-189
34. Chiang CY, Hu JW, Sessle BJ (1997) NMDA receptor involvement in neuroplastic changes induced by neonatal capsaicin treatment in trigeminal nociceptive neurons. J Neurophysiol 78:2799-2803
35. Coderre TJ, Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665-3670
36. Coppola G, Currà A, Sava SL, Alibardi A, Parisi V, Pierelli F, Schoenen J (2010) Changes in visual-evoked potential habituation induced by hyperventilation in migraine. J Headache Pain 11:497-503
37. Craig PJ, McAinsh AD, McCormack AL, Smith W, Beattie RE, Priestley JV, Yip JLY, Averill S, Longbottom ER, Volsen SG (1998) Distribution of the voltage-dependent calcium channel a(1A) subunit throughout the mature rat brain and its relationship to neurotransmitter pathways. J Comp Neurol 397:251-267
38. Cropper EC, Eisenman JS, Azmitis EC (1984) 5-HT-immunoreactive fibers in the trigeminal nuclear complex of the rat. Exp Brain Res 55:515-522
39. Cutrer FM (2010) Pathophysiology of migraine. Semin Neurol 33:120-130
40. DaSilva AFM, Becerra L, Makris N (2002) Somatotopic activation in the human trigeminal pain pathway. J Neurosci 22:8183-8192
41. Davidoff RA (1995) Migraine: manifestations, pathogenesis and management. FA Davis Company, Philadelphia, pp 115-180
42. De Carvalho LP, Bochet P, Rossier J (1996) The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. Neurochem Int 28:445-452
43. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192-196
44. De Marinis M, Pujia A, Natale L, D'arcangelo E, Accornero N (2003) Decreased habituation of the R2 component of the blink reflex in migraine patients. Clin Neurophysiol 114:889-893
45. De Marinis M, Pujia A, Colaizzo E, Accornero N (2007) The blink reflex in "chronic migraine". Clin Neurophysiol 118:457-463
46. De Tommaso M, Guido M, Libro G, Sciruicchio V, Puca F (2000) Zolmitriptan reverses blink reflex changes induced during the migraine attack in humans. Neurosci Lett 289:57-60
47. De Tommaso M, Murasecco D, Libro G, Guido M, Sciruicchio V, Specchio LM et al (2002) Modulation of trigeminal reflex excitability in migraine: effects of attention and habituation on the blink reflex. Int J Psychophysiol 44:239-249
48. De Tommaso M, Sardaro M, Pecoraro C, Di Fruscolo O, Serpino C, Lamberti P, Livrea P (2007) Effects of the remote C fibres stimulation induced by capsaicin on the blink reflex in chronic migraine. Cephalalgia 27:881-890
49. Del Rio MS, Linera JA (2004) Functional neuroimaging of headaches. Lancet Neurol 3:645-651
50. Demarquay G, Lothe A, Royet JP, Costes N, Mick G, Mauguiére F, Ryvlin P (2011) Brainstem changes in 5-HT1A receptor availability during migraine attack. Cephalalgia 31:84-94
51. Di Clemente L, Coppola G, Magis D, Fumal A, De Pasqua V, Di Piero V, Schoenen J (2007) Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine? Brain 130:765-770
52. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, Ferrari MD, Herzog J, van den Maagdenberg AM, Pusch M, Strom TM (2005) Mutation in the neuronal voltagegated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371-377
53. Dickson L, Finlayson K (2009) VPAC and PAC receptors: from ligands to function. Pharmacol Ther 121:294-316
54. Diener HC (1997) Positron emission tomography studies in headache. Headache 37:622-625
55. Diener HC (1999) How can PET scans help us understand headache mechanisms? Cephalalgia 23:15-18
56. Diener HC, May A (1996) Positron emission tomography studies in acute migraine attacks. In: Sandler M, Ferrari M, Harnett S (eds) Migraine: pharmacology and genetics. Chapman and Hall, London, pp 109-116
57. Dodick D, Silberstein S (2006) Central sensitization theory of migraine: clinical implications. Headache 46:S182-S191
58. Dykens JA, Sullivan SG, Stern A (1987) Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate. Biochem Pharmacol 36:211-217
59. Eastman CL, Guilarte TR (1990) The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine. Neurochem Res 15:1101-1107
60. Edvinsson L, Goadsby PJ (1995) Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia 15:272-276
61. Edvinsson L, Uddman R (2005) Neurobiology in primary headaches. Brain Res Rev 48:438-456
62. Ennis M, Aston-Jones G (1988) Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in brain. J Neurosci 8:3644-3657
63. Ennis M, Aston-Jones G, Shiekhattar R (1992) Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission. Brain Res 598:185-195
64. Ferrari MD (2005) Migraine as an ion-transporter disorder. Cephalalgia 25:842
65. Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW (1989) Serotonin metabolism in migraine. Neurology 39:1239-1242
66. Fields HL (1994) Pain modulation and the action of analgesic medications. Ann Neurol 35:S42-S45
67. Fields HL, Basbaum AI (1999) Central nervous system mechanisms of pain modulation. In: Wall PED, Melzack R (eds) Textbook of pain. Churchill Livingstone, Edinburgh
68. Gigler G, Szenasi G, Simo A, Levay G, Harsing LG Jr, Sas K (2007) Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils. Eur J Pharmacol 564:116-122
69. Goadsby PJ (1998) A triptan too far? J Neur Neurosurg Psych 64:143-147
70. Goadsby PJ (2002) Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia 22:107-111
71. Goadsby PJ (2005) Migraine, allodynia, sensitisation and all of that. Eur Neurol 53:10-16
72. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine-current understanding and treatment. N Engl J Med 346:257-270
73. Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG (2009) Tonabersat TON-01-05 Study Group. Randomized, doubleblind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia 7:742-750
74. Gobaille S, Kemmel V, Brumaru D, Dugave C, Aunis D, Maitre M (2008) Xanthurenic acid distribution, transport, accumulation and release in the rat brain. J Neurochem 105:982-993
75. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383:713-716
76. Guidetti P, Schwarcz R (1999) 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci 11:3857-3863
77. Guidetti P, Okuno E, Schwarcz R (1997) Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50:457-465
78. Guidetti P, Amori L, Sapko MT, Okuno E, Schwarcz R (2007) Mitochondrial aspartate aminotransferase: a third kynurenateproducing enzyme in the mammalian brain. J Neurochem 102:103-111
79. Guillemin GJ, Kerr SJ, Pemberton LA, Smith DG, Smythe GA, Armati PJ (2001) IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment. J Interf Cytokine Res 21:1097-1101
80. Guillemin GJ, Smith DG, Smythe GA, Armati PJ, Brew BJ (2003) Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 527:105-112
81. Guillemin GJ, Cullen KM, Lim CK, Smythe GA, Garner B, Kapoor V (2007) Characterization of the kynurenine pathway in human neurons. J Neurosci 27:12884-12892
82. Gupta VK (2006) Brainstem activity in migraine: primary or secondary? Arch Neurol 63:1347
83. Hadjikhani N, Sanchez del Rio M, Wu O (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98:4687-4692
84. Hajos M, Engberg G (1990) A role of excitatory amino acids in the activation of locus coeruleus neurons following cutaneous thermal stimuli. Brain Res 521:325-328
85. Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1293-1300
86. Hansen JM, Bolla M, Magis D, de Pasqua V, Ashina M, Thomsen LL, Olesen J, Schoenen J (2011) Habituation of evoked responses is greater in patients with familial hemiplegic migraine than in controls: a contrast with the common forms of migraine. Eur J Neurol 18:478-485
87. Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24:1-160
88. Heyliger SO, Goodman CB, Ngong JM, Soliman KF (1998) The analgesic effects of tryptophan and its metabolites in the rat. Pharmacol Res 38:243-250
89. Hillman D, Chen S, Aung TT, Cherksey B, Sugimori M, Llinas RR (1991) Localization of P-type calcium channels in the central nervous system. Proc Natl Acad Sci USA 88:7076-7080
90. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases nonalpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21:7463-7473
91. Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev 6:573-582
92. Hopf HC (1994) Topodiagnostic value of brainstem reflexes. Muscle Nerve 17:475-484
93. Jeong HJ, Chenu D, Johnson EE, Connor M, Vaughan CW (2008) Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain 4:54
94. Jhamandas K, Boegman RJ, Beninger RJ, Bialik M (1990) Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites. Brain Res 529:185-191
95. Jiang M, Behbehani MM (2001) Physiological characteristics of the projection pathway from the medial preoptic to the nucleus raphe magnus of the rat and its modulation by the periaqueductal gray. Pain 94:139-147
96. Kalen P, Strecker RE, Rosengren E, Bjorklund A (1989) Regulation of striatal serotonin release by the lateral habenula-dorsal raphe pathway in the rat as demonstrated by in vivo microdialysis: role of excitatory amino acids and GABA. Brain Res 492:187-202
97. Katsarava Z, Giffin N, Diener H-C, Kaube H (2003) Abnormal habituation of 'nociceptive' blink reflex in migraine-evidence for increased excitability of trigeminal nociception. Cephalalgia 23:814-819
98. Kaube H, Katsarava Z, Przywara S, Drepper J, Ellrich J, Diener H-C (2002) Acute migraine headache. Possible sensitization of neurons in the spinal trigeminal nucleus? Neurology 58:1234-1238
99. Kerr FWL, Olafson RA (1961) Trigeminal and cervical volleys. Arch Neurol 5:69-76
100. Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52:1319-1328
101. Kimura J (1983) Electrodiagnosis in diseases of nerve and muscle: principles and practice. FA Davis Company, Philadelphia
102. Knight YE, Goadsby PJ (2001) The periaqueductal gray matter modulates trigeminovascular input: a role in migraine? Neuroscience 106:793-800
103. Knight YE, Bartsch T, Kaube H, Goadsby PJ (2002) P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci 22:RC213
104. Knyihar-Csillik E, Toldi J, Krisztin-Peva B, Chadaide Z, Nemeth H, Fenyo R (2007a) Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid. Neurosci Lett 418:122-126
105. Knyihar-Csillik E, Toldi J, Mihaly A, Krisztin-Peva B, Chadaide Z, Nemeth H (2007b) Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model. J Neural Transm 114:417-421
106. Kors EE, Terwindt GM, Vermeulen F, Fitzsimons RB, Jardine PE, Heywood P, Love S, van den Maagdenberg A, Haan J, Frants RR, Ferrari MD (2001) Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 49:753-760
107. Lambert GA, Zagami AS (2009) The mode of action of migraine triggers: a hypothesis. Headache 49:253-275
108. Lance JW, Lambert GA, Goadsby PJ, Duckworth JW (1983) Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache 23:258-265
109. Lance JW, Lambert GA, Goadsby PJ, Zagami AS (1990) Contribution of experimental studies to understanding the pathophysiology of migraine. In: Sandler M, Collins GM (eds) Migraine: a spectrum of ideas. Oxford University Press, Oxford, pp 21-39
110. Lapin IP (1978) Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Transm 42:37-43
111. Leao AAP (1944) Spreading depression of activity in cerebral cortex. J Neurophysiol 7:359-390
112. Levine ES, Jacobs BL (1992) Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat. J Neurosci 12:4037-4044
113. Levy D, Strassman AM, Burstein R (2009) A critical view on the role of migraine triggers in the genesis of migraine pain. Headache 49:953-957
114. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646-657
115. Lovick TA, Wolstencroft JH (1983) Projections from brain stem nuclei to the spinal trigeminal nucleus in the cat. Neuroscience 9:411-420
116. Martella G, Costa C, Pisani A, Cupini LM, Bernardi G, Calabresi P (2008) Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. Cephalalgia 28:1315-1326
117. Matharu MS, Lee L, Kaube H, Friston KJ, Frackowiak RS, Goadsby PJ (2005)APETstudy exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 128:932-939
118. May A, Ophoff RA, Terwindt GM, Urban C, Vaneijk R, Haan J, Diener HC, Lindhout D, Frants RR, Sandkuijl LA, Ferrari Med (1995) Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet 96:604-608
119. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ (1998) Hypothalamic activation in cluster headache. Lancet 352:275-278
120. May A, Bahra A, Buchel C, Turner R, Goadsby PJ (1999) Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 46:791-794
121. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696
122. Messlinger K (2009) Migraine: when and how does the pain originate? Exp Brain Res 196:179-193
123. Morgan MM, Bobeck EN, Ingram SL (2009) Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Brain Res 1295:59-66
124. Moskowitz MA (1990) Basic mechanisms in vascular headache. Neurol Clin 8:801-815
125. Murphy AZ, Behbehani MM (1993) Electrophysiological characterization of the projection from the nucleus raphe magnus to the lateral reticular nucleus: possible role of an excitatory amino acid in synaptic activation. Brain Res 606:68-78
126. Neeb L, Meents J, Reuter U (2010) 5-HT1F receptor agonists: a new treatment option for migraine attacks? Neurotherapeutics 7:176-182
127. Nieber K, Poelchen W, Illes P (1997) Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. Br J Pharmacol 122:423-430
128. Nyholt DR, Lea RA, Goadsby PJ, Brimage PJ, Griffiths LR (1998) Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology 50:1428-1432
129. Obermann M, Yoon MS, Dommes P, Kuznetsova J, Maschke M, Weimar C, Limmroth V, Diener HC, Katsarava Z (2007) Prevalence of trigeminal autonomic symptoms in migraine: a population-based study. Cephalalgia 27:504-509
130. Olpe HR, Steinmann MW, Brugger F, Pozza MF (1989) Excitatory amino acid receptors in rat locus coeruleus. An extracellular in vitro study. Naunyn Schmiedebergs Arch Pharmacol 339:312-314
131. 2+ channel gene CACNL1A4. Cell 87:543-552
132. Oshinsky ML, Luo J (2006) Neurochemistry of trigeminal activation in an animal model of migraine. Headache 46:S39-S44
133. Palkovits M, Jacobowitz DM (1974) Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. II. Hindbrain (mesencephalon, rhombencephalon). J Comp Neurol 157:29-42
134. Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J (2000) Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. NeuroReport 11:3071-3075
135. Pardutz A, Hoyk Z, Varga H, Vecsei L, Schoenen J (2007) Oestrogenmodulated increase of calmodulin-dependent protein kinase II (CamKII) in rat spinal trigeminal nucleus after systemic nitroglycerin. Cephalalgia 27:46-53
136. Pascual J, del Arco C, Romón T, del Olmo E, Castro E, Pazos A (1996) Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 16:317-322
137. Ping HX, Wu HQ, Liu GQ (1990) Modulation of neuronal activity of locus coeruleus in rats induced by excitatory amino acids. Zhongguo Yao Li Xue Bao 11:193-195
138. Pinnock RD (1992) Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HTsensitive neurones in the rat dorsal raphe nucleus in vitro. Brain Res 583:237-246
139. Piovesan EJ, Kowacs PA, Oshinsky ML (2003) Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep 7:377-383
140. Politi V, Lavaggi MV, Di Stazio G, Margonelli A (1991) Indole-3- pyruvic acid as a direct precursor of kynurenic acid. Adv Exp Med Biol 294:515-518
141. Politi V, D'Alessio S, Di Stazio G, De Luca G (1996) Antioxidant properties of indole-3-pyruvic acid. Adv Exp Med Biol 398:291-298
142. Prescott C, Weeks AM, Staley KJ, Partin KM (2006) Kynurenic acid has a dual action on AMPA receptor responses. Neurosci Lett 402:108-112
143. Raskin NH, Hosobuchi Y, Lamb S (1987) Headache may arise from perturbation of the brain. Headache 27:416-420
144. Richter RC, Behbehani MM (1991) Evidence for glutamic acid as a possible neurotransmitter between the mesencephalic nucleus cuneiformis and the medullary nucleus raphe magnus in the lightly anesthetized rat. Brain Res 544:279-286
145. Richter F, Rupprecht S, Lehmenkühler A, Schaible H-G (2003) Spreading depression can be elicited in brainstem in immature but not adult rats. J Neurophysiol 90:2163-2170
146. Richter F, Lehmenkühler A, Schaible H-G (2005) Voltage-gated calcium channels are not involved in generation and propagation of spreading depression (SD) in the brainstem of immature rats. Neurosci Lett 390:15-20
147. Richter F, Bauer R, Lehmenkühler A, Schaible HG (2008) Spreading depression in the brainstem of the adult rat: electrophysiological parameters and influences on regional brainstem blood flow. J Cereb Blood Flow Metab 28:984-994
148. Rios C, Santamaria A (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 16:1139-1143
149. Schoenen J (1997) Acute migraine therapy: the newer drugs. Curr Opin Neurol 10:237-243
150. Schoenen J (2006) Neurophysiological features of the migrainous brain. Neurol Sci 27(Suppl 2):S77-S81
151. Schuh-Hofer S, Richter M, Geworski L, Villringer A, Israel H, Wenzel R, Munz LD, Arnold G (2007) Increased serotonin transporter availability in the brainstem of migraineurs. J Neurol 254:789-796
152. Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1-10
153. Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16-25
154. Sessle BJ, Hu JW, Dubner R, Lucier GE (1981) Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). II. Modulation of responses to noxious and nonnoxious stimuli by periaqueductal gray, nucleus raphe magnus, cerebral cortex, and afferent influences, and effect of naloxone. J Neurophysiol 45:193-207
155. Silberstein SD, Lipton RB, Goadsby PJ (1998) Headache in clinical practice. Isis Medical Media, Oxford, pp 41-90
156. Smith DH, Okiyama K, Thomas MJ, McIntosh TK (1993) Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury. J Neurosci 13:5383-5392
157. Sprenger T, Goadsby PJ (2010) What has functional neuroimaging done for primary headache and for the clinical neurologist? J Clin Neurosci 17:547-553
158. Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle TR (2005) SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain 113:422-426
159. Stovner L, Hogen K, Jensen R, Katsarava Z, Lipton R, Scher A (2007) The global burden of headache: a documentation of headache prevalence and disability world-wide. Cephalalgia 27:193-210
160. Tajti J, Uddman R, Edvinsson L (2001) Neuropeptide messengers in the migraine generator region of the human brainstem. Cephalalgia 21:96-101
161. Tassorelli C, Joseph SA (1995) Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res 682:167-181
162. Tavares RG, Tasca CI, Santos CE, Alves LB, Porciuncula LO, Emanuelli T (2002) Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40:621-627
163. Tortorella P, Rocca MA, Colombo B, Annovazzi P, Comi G, Filippi M (2006) Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J Neur Sci 244:137-141
164. Turski WA, Nakamura M, Todd WP, Carpenter BK, Whetsell WO Jr, Schwarcz R (1988) Identification and quantification of kynurenic acid in human brain tissue. Brain Res 454:164-169
165. Tyce GM (1990) Origin and metabolism of serotonin. J Cardiovasc Pharmacol 16(Suppl 3):S1-S7
166. Valentino RJ, Bey V, Pernar L, Commons KG (2003) Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity. J Neurosci 23:7155-7159
167. Vamos E, Pardutz A, Varga H, Bohar Z, Tajti J, Fulop F (2009) L-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus. Neuropharmacol 57:425-429
168. Vamos E, Fejes A, Koch J, Tajti J, Fulop F, Toldi J (2010) Kynurenate derivative attenuates the nitroglycerin-induced CamKIIalpha and CGRP expression changes. Headache 50:834-843
169. Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283-357
170. Vecsei L, Miller J, MacGarvey U, Beal MF (1992) Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain. Brain Res Bull 28:233-238
171. Veloso F, Kumar K, Toth C (1998) Headache secondary to deep brain implantation. Headache 38:507-515
172. 3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn Schmiedebergs Arch Pharmacol 352:263-275
173. Wang XM, Mokha SS (1996) Opioids modulate N-methyl-D-aspartic acid (NMDA)-evoked responses of trigeminothalamic neurons. J Neurophysiol 76:2093-2096
174. Weiller C, May A, Limmorth V, Jüptner M, Kaube H, Schayck R, Coenen HH, Diener HC (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658-660
175. Welch KM, Cao Y, Aurora S, Wiggins G, Vikingstad EM (1998) MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 51:1465-1469
176. Welch KM, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629-637
177. Westenbroek RE, Sakurai T, Elliott EM, Hell JW, Starr TVB, Snutch TP, Caterall WA (1995) Immunochemical identification and subcellular distribution of the a(1A) subunits of brain calcium channels. J Neurosci 15:6403-6418
178. Wise SP, Jones EG (1977) Cells of origin and terminal distribution of descending projections of the rat somatic sensory cortex. J Comp Neurol 175:129-157
179. Wolf H (1974) The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. Scand J Clin Lab Invest 136:1-186
180. World Health Organization (2001) The World Health Report 2001. WHO, Geneva
181. Yokota T (1988) Anatomy and physiology of intra- and extracranial nociceptive afferents and their central projections. In: Olesen J, Edvinsson L (eds) Basic mechanisms of headache. Elsevier, New York
182. Yu P, Li Z, Zhang L, Tagle DA, Cai T (2006) Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene 365:111-118
183. Zsizsik BK, Hardeland R (2002) Formation of kynurenic and xanthurenic acids from kynurenine and 3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum: role of a novel, oxidative pathway. Comp Biochem